FDA Yanks Ozone-Depleting Inhaler From Market

Law360, New York (September 22, 2011, 3:24 PM EDT) -- The U.S. Food and Drug Administration announced Thursday it was taking the only agency-approved over-the-counter asthma inhaler off the market at the end of the year because it uses a compound that harms the ozone layer.

Primatene Mist, an epinephrine inhaler manufactured by Armstrong Pharmaceuticals Inc., will not be made or sold after Dec. 31, the FDA said. The product uses chlorofluorocarbons, or CFCs, to propel an asthma-relief medication out of the inhaler into a user's lungs.

The agency said it made the move in order...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.